Company Filing History:
Years Active: 1999
Title: Brid T. Devlin: Pioneering Innovations in Pharmaceutical Dosage Forms
Introduction
Brid T. Devlin, an accomplished inventor based in Conshohocken, PA, has made significant contributions to the field of pharmaceuticals. With a focus on innovative dosage forms, he holds two patents that highlight his expertise in creating effective solutions for medication delivery.
Latest Patents
Devlin's most recent patents are centered around a substantial advancement in soft gelatin pharmaceuticals. His first patent involves a substantially translucent, semi-solid fill material for soft gelatin capsules, which contains a therapeutically effective amount of a pharmaceutical dissolved or suspended in the semi-solid. This innovative formulation is designed to be sufficiently viscous, preventing it from being readily expelled at room temperature using a syringe.
The second patent also pertains to a semi-solid fill material for soft gelatin capsules, specifically incorporating an antiflatulent agent. Similar to the first, this invention ensures that the semi-solid mix cannot be easily expelled at room temperature, thus enhancing the usability of the dosage form.
Career Highlights
Brid T. Devlin has worked with notable companies in the pharmaceutical sector, including Johnson & Johnson's McNeil Consumer Healthcare division. His career reflects a deep commitment to improving pharmaceutical formulations, contributing to more effective medicinal delivery systems.
Collaborations
Throughout his career, Devlin has collaborated with talented professionals, including coworkers like Michael R. Hoy and Sharon L. Cody. These collaborations have undoubtedly fueled his innovative prowess and contributed to the successful development of his patented technologies.
Conclusion
Brid T. Devlin stands out as a notable inventor whose work in pharmaceutical dosage forms signifies a step forward in medicine. His patents showcase a dedication to harnessing innovation for practical applications, ultimately enhancing patient care through advanced medication delivery systems. As pharmaceutical technology evolves, Devlin's contributions will likely continue to influence the industry positively.